The Bariatrics Boom
Executive Summary
Over the last 20 years, obesity has become a disease of epidemic proportions, and the prevalence of this complex disease continues to rise. Amid this epidemic, opportunities abound for companies with surgical and nonsurgical solutions, making this market one of the hottest new growth areas for medical technology companies. At this year's meeting of the American Society of Bariatric Surgery (ASBS), manufacturers showcased some of the latest surgical solutions for treating obesity and the morbidly obese.
You may also be interested in...
Satiety: Treating Obesity Beyond Quality of Life
Obesity is no longer merely a lifestyle-related condition; it's a worldwide epidemic with life-threatening consequences. Satiety is developing a device-based alternative to surgery that could expand the market for both physicians and patients.
EnteroMedics' Weighty Financing for Obesity
EnteroMedics recently earned the distinction of closing the second-largest financing for a private medical device company in 2006. Its success was undoubtedly due to the company's attractive position at the junction of two of the device industry's hottest markets: obesity and neuromodulation. EnteroMedics is developing an implantable impulse generator that it hopes will address multiple mechanisms in obesity.
Positioning Acomplia: Has the Drug Arrived Before the Disease?
Sanofi-Aventis is the envy of many as it awaits approval for fat-busting metabolic syndrome drug, Acomplia. But obesity is rarely reimbursed; metabolic syndrome still undefined.